In non-alcoholic fatty liver disease (NAFLD), NLRC4 contributes to the polarization of TAM to M2 type and the production of IL-1β and VEGF, thereby promoting the growth of tumor (62). Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.